(M2 PRESSWIRE via COMTEX News Network) -- BUYINS.NET, www.buyins.net(link broken), is reiterating coverage of Signalife, Inc. (AMEX: SGN) after releasing the latest short sale data to July 2007. From August 2005 to July 2007 approximately 60 million total aggregate shares of SGN have traded for a total dollar value of nearly $122.5 million. The total aggregate number of shares shorted in this time period is approximately 8.7 million shares. The SGN SqueezeTrigger price of $2.04 is the volume weighted average short price of all short selling in SGN.
The next of several short squeezes is expected to begin when shares of SGN close above $0.83, where approximately 288,000 shares have been shorted. With the stock approaching its first of several SqueezeTrigger Levels, a short squeeze can begin imminently. Over 288,000 shares have been shorted at an average price of $.83 and the stock closed at $.80 on Wednesday.
Once it reaches $.83 shorts begin to cover. When the stock closes above $2.04, all shares that have been shorted on SGN will be out-of-the-money.
About Squeezetrigger:
Short Squeezes are one of the most profitable trading events in the stock market. Using the SqueezeTrigger Strategy it is now possible for the first time in history to know the exact time, price, and size that a short squeeze will start!
About Signalife, Inc.
Signalife, Inc. is a life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. Signalife is publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is Signalife.com. Clear Data. Trusted Results.
This is a public press release privacy statement.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment